FDA label
What is Epidiolex used for?
Epidiolex contains cannabidiol. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Epidiolex?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Epidiolex, solution
Indications and Usage, quoted from the label by Jazz Pharmaceuticals, Inc. (NDA210365). Cross-references to other label sections are left out.
EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older.
Source: DailyMed label, set id 8bf27097-4870-43fb-94f0-f3d0871d1eec, version 35, effective May 29, 2026. NDC 70127-100, one of 1 listing for this product.
Questions
What is Epidiolex used for?
The FDA label says: “EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.